biote Corp.

BTMD Healthcare Medical Care Facilities

biote Corp.’s revenue for fiscal 2025 (year ended December 2025) was $192.2 million, down 2.52% from fiscal 2024.

Revenue
−9.48%
EPS
−330.0%
Free cash flow
−174.2%
Total debt
+16.0%

Quarter to June 2026, against a year earlier

1.06 0.02 +1.92%
Market cap
$37.4M
P/E
6.6×
Fwd P/E
−5.4×
Dividend yield
—
F-score
7/9
Altman Z
2.65
Beneish M
−2.72
Dividend safety
n/a

biote Corp. (BTMD) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, biote Corp. (BTMD) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.0× (March 2022) to 2.0× (July 2024); the current reading is higher than 42% of that period. That is below the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.9× (39.80%)
FY2024 1.4× 80.84%
FY2023 0.8× 89.86%
FY2022 0.4× —
FY2021 0.0× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.9× 18.96%
Mar 2026 0.8× (11.85%)
Dec 2025 0.9× (1.27%)
Sep 2025 0.9× (18.83%)
17 more quarters

Against its own ten years

Low 0.0× High 2.0×
Ten-year median 0.8×
Current reading's percentile 31

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on BTMD